Über 5-FU hinaus: Zukünftige therapeutische Ansätze zur Behandlung des kolorektalen Karzinoms. Zum Vortrag «Beyond 5-FU: Future Directions in the Treatment of Colorectal Cancer»von D.G. Haller (University of Pennsylvania Cancer Center Medical und Hematology-Oncology Outpatient Practice, Hospital of the University of Pennsylvania, Philadelphia, PA

Publisher： Karger

E-ISSN： 2296-5262|23|5|5-8

ISSN： 2296-5270

Source： Oncology Research and Treatment, Vol.23, Iss.5, 2004-11, pp. : 5-8

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Aktuelle Strategien bei der Behandlung des metastasierten kolorektalen Karzinoms. Zum Vortrag «Current Strategies in the Treatment of Metastatic Colorectal Cancer» von M.L. Rothenberg (Vanderbilt University Medical Center and E. Bronson Ingram Cancer Center at Vanderbilt, Nashville, TN)

By  

Oncology Research and Treatment, Vol. 23, Iss. 5, 2004-11 ,pp. : 3-4

Karger

Access to resources Recommend Favorite

The Role of 5-Fluorouracil (5-FU) Reintroduction with Irinotecan or Oxaliplatin in Truly 5-FU-Refractory Advanced Colorectal Cancer Patients

By  

Oncology, Vol. 68, Iss. 2-3, 2005-07 ,pp. : 212-216

Karger

Access to resources Recommend Favorite

Second-Line Chemotherapy with a Hybrid-Alternating Regimen of Bolus 5FU Modulated by Methotrexate and Infusional 5FU Modulated by Folinic Acid in Patients with Metastatic Colorectal Cancer Pretreated with 5FU

By  

Oncology, Vol. 63, Iss. 3, 2002-10 ,pp. : 219-225

Karger

Access to resources Recommend Favorite

Gefitinib in Combination with 5-Fluorouracil (5-FU)/Folinic Acid and Irinotecan in Patients with 5-FU/Oxaliplatin- Refractory Colorectal Cancer: A Phase I/II Study of the Arbeitsgemeinschaft für Internistische Onkologie (AIO)

By  

Oncology Research and Treatment, Vol. 29, Iss. 12, 2006-12 ,pp. : 563-567

Karger

Access to resources Recommend Favorite

High-Dose Irinotecan plus LV5FU2 or Simplified LV5FU (HD-FOLFIRI) for Patients with Untreated Metastatic Colorectal Cancer: A New Way to Allow Resection of Liver Metastases?

By  

Oncology, Vol. 74, Iss. 1-2, 2008-06 ,pp. : 17-24

Karger

Access to resources Recommend Favorite